Be Part of the CURE banner_DRI lobby

Jay S. Skyler, M.D.

"If type 1 diabetes is to be conquered, it is necessary to stop immune destruction of β-cells, to replace or regenerate β-cells, and to preserve β-cell function and mass.

Jay S. Skyler, M.D., M.A.C.P., is a Professor of Medicine, Pediatrics and Psychology at the University of Miami Miller School of Medicine and Deputy Director for Clinical Research and Academic Programs at the Diabetes Research Institute. He is also a member of the University of Miami Interdisciplinary Stem Cell Institute.

Dr. Skyler's career in diabetes spans nearly five decades, during which time his research interests have concentrated in clinical aspects of diabetes, focusing on improving the care of type 1 diabetes through meticulous glycemic control, psychosocial and behavioral support, and particularly immune intervention. He has had continuous research support from the National Institutes of Health since 1979.

He was Study Chairman for the nationwide multi-center Diabetes Prevention Trial for Type 1 diabetes (DPT-1) and was Study Chairman of its successor, Type 1 Diabetes TrialNet, these two programs spanning 22 years. 

He is a past President of the American Diabetes Association, the International Diabetes Immunotherapy Group, and the Southern Society for Clinical Investigation, and was a Vice-President of the International Diabetes Federation.  He served as a member of the Endocrinology, Diabetes, and Metabolism Subspecialty Examining Board of the American Board of Internal Medicine, as Chairman of the Council of Subspecialty Societies of the American College of Physicians (ACP) and a member of the ACP Board of Regents.  A frequent national and international lecturer, Dr. Skyler has been an author, editor and co-editor of numerous books, monographs, chapters and articles.  He was founding Editor-in-Chief of Diabetes Care.

You can access Dr. Skyler's CV and full Biosketch here.

Keep up with our progress toward a cure & more

Be a DRI Insider - Get News!